Cost-Effectiveness Analysis on 5 Drug Therapeutic Regimens for Children Pneumonia / 中国药房
China Pharmacy
;
(12)2007.
Article
in Chinese
| WPRIM
| ID: wpr-529800
ABSTRACT
OBJECTIVE:
To compare the pharmacoeconomic efficacies of 5 drug therapeutic regimens for children pneumonia.METHODS:
Using retrospective study and cost-effectiveness analysis to compare the pharmacoeconomic efficacies among the following 5 regimens in treating children pneumoniaamoxicillin sodium/clavulanate potassium(Group A),cefotaxime sodium(Group B),cefoperazone sodium/sulbactam sodium(Group C),cefuroxime sodium(Group D),and azithromycin(Group E).RESULTS:
The effective rates of the 5 groups(A,B,C,D and E) were 80.43%,76.09%,65.12%,77.27%,and 91.30%,respectively,and the cost-effectiveness ratios were 1 595.06,1 225.38,1 669.69,1 284.83,and 697.84,respectively.CONCLU-SIONThe regimen of azithromycin(group E) is the optimal one among the 5 groups for children pnemonia.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Health economic evaluation
/
Observational study
Language:
Chinese
Journal:
China Pharmacy
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS